Tuesday, January 23, 2007 6:29:33 PM
http://www.cashcrate.com/index.php?ref=159394
Recent DYN News
- Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/02/2024 08:10:00 PM
- Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer • GlobeNewswire Inc. • 03/27/2024 08:05:00 PM
- Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium • GlobeNewswire Inc. • 03/27/2024 12:30:00 PM
- Dyne Therapeutics Announces CEO Transition • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days • GlobeNewswire Inc. • 03/13/2024 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 09:36:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 09:35:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 09:35:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:53:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 01:19:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 01:18:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 01:16:36 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/05/2024 01:22:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:41:52 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/05/2024 12:40:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/05/2024 12:35:27 PM
- Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 03/05/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 02:37:54 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2024 02:33:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:08:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 12:49:10 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 10:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:27:23 PM
- Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference • GlobeNewswire Inc. • 02/14/2024 09:15:16 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM